Tivic Health Systems, Inc. (disclosed in the filing as Valion Bio, Inc.) announced that Interim Chief Executive Officer Dean Zikria has established a strategic agenda following his first 30 days in ...

Zikria's strategic review has set a focused agenda built on three priorities: * Advancing the development of Entolimod and ...

In the early hours of February 5, 1989, three men entered a room known as the irradiation chamber at a factory near San ...

Right now, there are over 400 nuclear power plants operating in 20 countries. Could they be ticking time bombs, potentially ...

A case report describes a child with B-ALL who recovered from probable blinatumomab-associated lung injury and completed a ...

Neoplastic lesions mimicking cellulitis and erysipelas When observing redness, swelling, and warmth in the lower limbs, one ...

Dark tourism spots such as Chernobyl, Hiroshima and the killing fields in Cambodia draw thousands of tourists a year – Amelia ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the European Commission (EC) has approved KEYTRUDA ® (pembrolizumab), Merck’s anti-PD-1 therapy, in combination ...

* Valion holds an exclusive worldwide license from Statera Biopharma to develop and commercialize Entolimod for acute radiation syndrome, radiation-induced neutropenia with an exclusive option for ...

Actinium Pharmaceuticals, Inc. (NYSE American: ATNM) (Actinium or the Company), a pioneer in differentiated targeted ...

A synthetic version of an embryo-derived peptide protected rat hearts from radiotherapy damage, reducing hypertrophy, ...

Velocity Bioworks' San Antonio facility offers process development, analytical services, and early-phase clinical drug ...